Novel platform biotechnology for the production of natural next generation 3D nanomaterials and nanodevices

用于生产天然下一代 3D 纳米材料和纳米器件的新型平台生物技术

• 批准号: 131843
• 金额: $ 26.3万
• 依托单位: CELLUCOMP LIMITED
• 依托单位国家: 英国
• 项目类别: Feasibility Studies
• 财政年份: 2015
• 资助国家: 英国
• 起止时间: 2015 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=131843
• 关键词: Novel; platform; biotechnology; production; natural

Arraying of chemical groups and functional peptides on the surface of engineered, safe (non-infectious) virus-like nanoparticles (VNPs), permits the formation of biomimetic multifunctional and highly reactive nanoscale structures. This project seeks to develop the next generation functional 3D nanomaterials we via the incorporation of such multifunctional VNPs into a low cost nanocellulose matrix which has excellent mechanical characteristics, thus allowing production of innovative functional and catalytic nanoreactors, coatings, filters and other devices

将化学基团和功能肽排列在工程化的、安全的（非感染性的）病毒样纳米颗粒（VNPs）的表面上，允许形成仿生多功能和高反应性的纳米级结构。该项目旨在开发下一代功能性3D纳米材料，我们通过将这种多功能VNPs结合到具有优异机械特性的低成本纳米纤维素基质中，从而允许生产创新的功能性和催化性纳米反应器，涂层，过滤器和其他设备。